655 filings
Page 8 of 33
8-K
tknygc7y8jq
23 Jun 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:24pm
8-K
68olky2 h8udz
18 Jun 20
Regulation FD Disclosure
1:26pm
8-K
6ne09blsl 5w
15 Jun 20
Vaxart, Inc. Appoints New CEO to Accelerate Advancement of COVID-19 and Other Programs
5:25pm
8-K
niv7l5n0 dpwph7ed
9 Jun 20
Departure of Directors or Certain Officers
4:26pm
DEFA14A
mc182l 2ud
15 May 20
Additional proxy soliciting materials
4:06pm
8-K
lt24fvba
12 May 20
Vaxart Announces First Quarter 2020 Financial Results
4:04pm
8-K
75o4xrf
29 Apr 20
Vaxart Announces Corporate Update for First Quarter 2020
12:00am
DEFA14A
nsg h9ohpdj
24 Apr 20
Additional proxy soliciting materials
4:02pm
8-K
d2bn rx1j5
14 Apr 20
Departure of Directors or Certain Officers
4:26pm
8-K
oxklxo48139ccy
19 Mar 20
Vaxart Announces Fourth Quarter and Full Year 2019 Financial Results
4:04pm
8-K
o8239dm c29kd64
2 Mar 20
Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
2:48pm
424B5
p79b5n9kq0dvf
2 Mar 20
Prospectus supplement for primary offering
11:44am
SEC STAFF
7a6dj68elrm66up
18 Feb 20
SEC staff action: Order
12:00am
SEC STAFF
megy87udv1x92x
6 Feb 20
SEC staff action: Order
12:00am
8-K
dbjctczvgzivus wd
2 Jan 20
Cost Associated with Exit or Disposal Activities
4:04pm
8-K
k28k48r3
4 Dec 19
Departure of Directors or Certain Officers
4:05pm